Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.

Sci Rep · 2017 · PMC5382875 · PMID 28383524

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

However, the body weight of mice treated with DTX showed a decreasing trend, which might be associated with the toxicity of the nonionic-surfactant Tween-80 in the DTX formulations (Duopafei ® ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.